Risperdal Gynecomastia Lawsuit Center

After taking a medication prescribed to treat bipolar disorder, schizophrenia and other conditions, more and more men and young boys have joined a growing Risperdal lawsuit litigation involving individuals who allegedly developed gynecomastia, a serious and embarrassing condition referring to male breast growth. These cases seek compensation for out-of-pocket medical expenses, lost wages, pain and suffering and other damages incurred as a result of this antipsychotic drug’s side effects, which may require patients to undergo mastectomy procedures and liposuction.

To find out if you are eligible to file a Risperdal gynecomastia lawsuit, consider calling an attorney at Bernstein Liebhard LLP who can help you navigate the legal process. The Firm is currently offering free and confidential case evaluations to those who took this medication, and is eager to help you take action against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc.

Who Can File a Risperdal Gynecomastia Lawsuit?

Any individual who may have experienced swollen breast tissue, tenderness or pain in the breast, or nipple discharge from one or both breasts may be eligible to file a Risperdal gynecomastia lawsuit.

Prescribed in the treatment of bipolar disorder and schizophrenia in adults and adolescents, Risperdal was approved by the U.S. Food and Drug Administration (FDA) in 1993, and is also used to treat irritability in children ages 5-to-16 years of age on the autism spectrum. A growing body of research also suggests that Risperdal is frequently prescribed off-label to treat ADHD.

risperdal gynecomastiaRisperdal lawsuits allege that Johnson & Johnson and Janssen failed to warn men and young boys about the risk for male breast growth, which may stem from elevated levels of a hormone associated with breast development in women and lactation in nursing mothers. In 2006, research published in the Journal of Clinical Psychopharmacology first lent evidence to this association, and a study published in a 2009 issue of the Journal of Child and Adolescent Psychopharmacology showed that levels of this hormone, prolactin, were shown to stay elevated for up to two years after discontinued use of the drug. Risperdal gynecomastia lawsuits have also been filed by men who experienced galactorrhoea, or unexpected breast milk production.

At this point, the majority of Risperdal gynecomastia lawsuit filings have been individual cases, rather than class actions. Court documents show that over 200 claims alleging this complication and other side effects are pending in a consolidated litigation underway in the Philadelphia Court of Common Pleas.

Johnson & Johnson has come under fire recently for its off-label promotion of Risperdal and other drugs. According to an important settlement reached in November 2013, the company agreed to pay over $2.2 billion to the U.S. Department of Justice after it was found that certain medications were promoted for off-label uses. Risperdal, for example, was allegedly marketed to children before it was approved by the FDA for pediatric uses, and also to elderly patients with dementia. Johnson & Johnson also reportedly paid kickbacks to doctors and pharmacists in exchange for more scripts.

Filing a Risperdal Lawsuit

If you are interested in joining the growing Risperdal gynecomastia lawsuit litigation, contact an attorney at Bernstein Liebhard LLP to learn more about your legal rights. You may be eligible to receive compensation for medical bills, lost wages and other out-of-pocket costs. Call the following number directly: